**Margreet Franken, PhD** is a senior researcher at the institute for Medical Technology Assessment (iMTA), Erasmus University Rotterdam, The Netherlands. She obtained a Bachelor degree in Nursing (1992), after which she specialised in coronary (1995) and intensive care nursing (1998). From 1992 until 2008 she worked as a quality care manager, clinical nurse educator, and specialised coronary and intensive care nurse in hospitals in Arnhem, Rotterdam and Christchurch (New Zealand). In 2008, Margreet obtained a masters degree (cum laude) in Health Economics, Policy and Law from the Erasmus University in Rotterdam. Since this time she has been working as a researcher at the institute for Medical Technology Assessment of the institute of Health Policy and Management at the Erasmus University in Rotterdam. In 2014, Margreet obtained her PhD on drug reimbursement decision making. She has been involved in setting up several patient registries in oncology. Her research interests are in the field of health economics and include drug reimbursement policies and outcomes research using real-world data. She is currently involved in disease registries for melanoma, multiple myeloma, colon and lung cancer.